TDP1 and glioblastoma: In our study, we found that the TDP1/TOP1 activity ratio was superior to TDP1/TOP1 protein ratio as a predictor for the response of GBM cell lines to irinotecan treatment, as indicated by the irinotecan IC50s measured here.